Daily non-political popular news in brief.
Novel medication improves ovarian cancer treatment
10-31-2007 · EurekAlert!A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anticancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Read more »
Keywords: novel, medication, improves, ovarian, cancer, treatment, improve
« Previous | Next »
Similar news on "Novel medication improves ovarian cancer treatment":
- Australian researchers develop treatment to treat obesity
11-06-2007 · EurekAlert!
A team of Australian researchers have developed a novel way to control the extreme weight loss, common in late-stage cancer, which often speeds death. The findings published today in Nature Medicine suggest it may soon be possible to prevent this condition, giving people the strength to survive treatment and improve their chances of recovery.
Similar news · Read more »
- Anthracyclines improve survival in HER2-positive breast cancer patients
12-25-2007 · EurekAlert!
Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online Dec. 25 in the Journal of the National Cancer Institute.
Similar news · Read more »
- Researchers identify ovarian cancer biomarkers
03-07-2007 · EurekAlert!
Researchers have identified markers unique to the cells of blood vessels running through ovarian tumors. The finding, while preliminary, could one day improve screening, diagnosis and treatment for this disease.
Similar news · Read more »
- Combining therapies can improve survival for early-stage breast cancer patients
04-03-2007 · EurekAlert!
Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen. But a combination of tamoxifen and ovarian suppression -- treatment to stop the ovaries from functioning -- did not show any additional benefits, according to two randomized clinical trials published in the April 4 Journal of the National Cancer Institute.
Similar news · Read more »
- Gene therapy, cancer-killing viruses and new drugs highlight novel approaches to cancer treatment
04-17-2007 · EurekAlert!
Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.
Similar news · Read more »
- Jefferson researchers boost immune 'killer cells,' increase antibody effectiveness against cancer
04-18-2007 · EurekAlert!
Researchers have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body. They have shown in laboratory studies that adding such cells to anti-cancer therapies involving monoclonal antibody drugs such as Herceptin, which targets the HER2/neu protein on breast cancer cells, is more effective in killing cancer cells, and perhaps someday may improve treatments.
Similar news · Read more »
- Research highlights important indicators of early-stage ovarian cancer
11-09-2007 · EurekAlert!
New research explains why some ovarian cancer patients are dying, while others survive, despite similar surgical and post-operative treatment.
Similar news · Read more »
- Research suggests new treatment suitable for all patients
01-01-2008 · EurekAlert!
New research at Wake Forest University Baptist Medical Center suggests that a three-drug cocktail may one day improve outcomes in patients with glioblastoma multiforme, a type of brain tumor with a dismal prognosis. Two of the drug candidates have been developed, and the team is working on the third -- all targeted to kill or impair cancer cells and spare healthy brain.
Similar news · Read more »
- Study offers innovative profile of enzyme that aids tumor growth
10-20-2006 · EurekAlert!
Using an innovative profiling strategy, scientists at the Scripps Research Institute have characterized an enzyme that is "highly elevated" in aggressive human tumor cells. When the enzyme, KIAA1363, was inactivated, it impaired tumor growth and migration in both ovarian and breast cancer cells, suggesting that inhibitors of this enzyme may prove valuable in the treatment of multiple types of cancer.
Similar news · Read more »
- Sunshine pill for prostate cancer in 2009
01-16-2007 · EurekAlert!
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
Similar news · Read more »
